Giuseppe Morelli

2.2k total citations
52 papers, 1.3k citations indexed

About

Giuseppe Morelli is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Giuseppe Morelli has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 26 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Giuseppe Morelli's work include Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (20 papers) and Hepatitis C virus research (19 papers). Giuseppe Morelli is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (20 papers) and Hepatitis C virus research (19 papers). Giuseppe Morelli collaborates with scholars based in United States, Italy and United Kingdom. Giuseppe Morelli's co-authors include David R. Nelson, Roberto J. Firpi, Consuelo Soldevila‐Pico, Roniel Cabrera, Virginia Clark, Victor I. Machicao, Paul Y. Kwo, Michael Fried, Cynthia Levy and Mitchell L. Shiffman and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Giuseppe Morelli

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Morelli United States 19 912 788 351 195 132 52 1.3k
Ziv Ben‐Ari Israel 20 810 0.9× 627 0.8× 405 1.2× 132 0.7× 72 0.5× 57 1.2k
Maria Rendina Italy 17 604 0.7× 595 0.8× 217 0.6× 69 0.4× 101 0.8× 54 1.0k
John Boitnott United States 15 1.2k 1.3× 1.1k 1.3× 357 1.0× 155 0.8× 89 0.7× 20 1.7k
Albert D. Min United States 22 1.6k 1.7× 1.5k 1.9× 330 0.9× 44 0.2× 154 1.2× 56 1.9k
M.L. Ribero Italy 19 940 1.0× 934 1.2× 220 0.6× 128 0.7× 124 0.9× 35 1.3k
S. Brillanti Italy 21 1.9k 2.1× 1.7k 2.1× 194 0.6× 58 0.3× 135 1.0× 51 2.2k
Kuo‐Chin Chang Taiwan 24 877 1.0× 947 1.2× 328 0.9× 80 0.4× 80 0.6× 82 1.4k
G. Bellati Italy 23 1.2k 1.3× 1.0k 1.3× 271 0.8× 35 0.2× 55 0.4× 49 1.4k
Laure Elkrief France 18 1.1k 1.2× 1.2k 1.5× 396 1.1× 50 0.3× 33 0.3× 45 1.5k
Trevor Lissoos United States 17 396 0.4× 844 1.1× 366 1.0× 82 0.4× 77 0.6× 41 1.3k

Countries citing papers authored by Giuseppe Morelli

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Morelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Morelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Morelli more than expected).

Fields of papers citing papers by Giuseppe Morelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Morelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Morelli. The network helps show where Giuseppe Morelli may publish in the future.

Co-authorship network of co-authors of Giuseppe Morelli

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Morelli. A scholar is included among the top collaborators of Giuseppe Morelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Morelli. Giuseppe Morelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmud, Nadim, Justin Boike, Bartley Thornburg, et al.. (2023). The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology. 77(6). 2041–2051. 7 indexed citations
2.
Amoroso, Pietro, Gennaro Lettieri, Paola Pierri, et al.. (2020). Changing epidemiology of acute liver failure in Italy: a single-center experience over 25 years. Minerva Medica. 111(4). 330–336. 1 indexed citations
3.
Lok, Anna S., Mark Sulkowski, Jens Kort, et al.. (2019). Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy. Gastroenterology. 157(6). 1506–1517.e1. 34 indexed citations
4.
Ayoub, Fares, Cesar Trillo‐Alvarez, Giuseppe Morelli, & Jorge Lascano. (2018). Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease. World Journal of Hepatology. 10(1). 34–40. 29 indexed citations
5.
Lawitz, Eric, Edward Gane, E. Cohen, et al.. (2018). Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease. Kidney International Reports. 4(2). 257–266. 17 indexed citations
6.
Welzel, Tania M., David R. Nelson, Giuseppe Morelli, et al.. (2016). Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study. Gut. 66(10). 1844–1852. 61 indexed citations
7.
Morelli, Giuseppe, Roberto J. Firpi, Joy Peter, et al.. (2015). Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination with Sofosbuvir in Naive Subjects with HCV Genotype 1 Short Title: Telaprevir & Sofosbuvir in HCV Genotype 1. Journal of Gastroenterology and Hepatology Research. 4(5). 1599–1604. 2 indexed citations
8.
Morelli, Giuseppe, Roberto J. Firpi, Lucy Akushevich, et al.. (2015). Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination With Sofosbuvir in Naive Subjects Infected With Hepatitis C Virus Genotype 1. Journal of Gastroenterology and Hepatology Research. 4(5). 1599–1604. 1 indexed citations
9.
Brown, Robert S., Jacqueline G. O’Leary, K. Rajender Reddy, et al.. (2015). Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network. Liver Transplantation. 22(1). 24–33. 84 indexed citations
10.
Michaels, Anthony, Renumathy Dhanasekaran, David P. Foley, et al.. (2013). Hepatic Preservation Injury: Severity of Hepatitis C Recurrence and Survival After Liver Transplantation. Digestive Diseases and Sciences. 58(5). 1403–1409.
11.
Cabrera, Roniel, Renumathy Dhanasekaran, James G. Caridi, et al.. (2011). Impact of Transarterial Therapy in Hepatitis C-Related Hepatocellular Carcinoma on Long-term Outcomes After Liver Transplantation. American Journal of Clinical Oncology. 35(4). 345–350. 12 indexed citations
12.
Firpi, Roberto J., Virginia Clark, Consuelo Soldevila‐Pico, et al.. (2009). The natural history of hepatitis C cirrhosis after liver transplantation. Liver Transplantation. 15(9). 1063–1071. 64 indexed citations
13.
Morelli, Giuseppe, et al.. (2009). Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer. 4(1). 2–2. 3 indexed citations
14.
Cabrera, Roniel, Miguel Ararat, Consuelo Soldevila‐Pico, et al.. (2009). Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transplantation. 15(2). 216–222. 37 indexed citations
15.
Bacon, Bruce R., Mitchell L. Shiffman, Flavia Mendes, et al.. (2009). Retreating chronic hepatitis C with daily interferon alfacon‐1/ribavirin after nonresponse to pegylated interferon/ribavirin. Hepatology. 49(6). 1838–1846. 60 indexed citations
16.
Morelli, Giuseppe, Alan Reed, Roberto J. Firpi, et al.. (2006). Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosis. Liver Transplantation. 12(2). 306–309. 4 indexed citations
17.
D’Alessandro, Paolo, et al.. (2004). Rvfini Antichensis Commentaria in metra Terentiana et De compositione et de numeris oratorvm.
18.
Morelli, Giuseppe. (2001). Teatro attico e pittura vascolare : una tragedia di Cheremone nella ceramica italiota. G. Olms eBooks. 1 indexed citations
19.
Krovacek, Karel, et al.. (1993). Fatal septicaemia caused by Aeromonas hydrophila in a patient with cirrhosis. Comparative Immunology Microbiology and Infectious Diseases. 16(4). 267–272. 16 indexed citations
20.
Gentili, Bruno, et al.. (1974). Antifonte oratore e Antifonte sofista. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziv Ben‐Ari Breakdown of academic impact, for papers by Maria Rendina Breakdown of academic impact, for papers by John Boitnott Breakdown of academic impact, for papers by Albert D. Min Breakdown of academic impact, for papers by M.L. Ribero Breakdown of academic impact, for papers by S. Brillanti Breakdown of academic impact, for papers by Kuo‐Chin Chang Breakdown of academic impact, for papers by G. Bellati Breakdown of academic impact, for papers by Laure Elkrief Breakdown of academic impact, for papers by Trevor Lissoos
Rankless by CCL
2026